Case Studies
Results 1 - 10 of 56 Total Hits, Sorted by Relevance.

First | Previous set of DocumentsPrevious | NextNext set of Documents | Last
Direct access to this research is not included with your membership level.This is a pharma specific study.Tecfidera Case Study: Using Safety as a Springboard for Blockbuster Status This document contains Metrics and Graphics.This document contains Metrics and Graphics.
Non-members: Click here to review a complimentary excerpt from "Tecfidera Case Study: Using Safety as a Springboard for Blockbuster Status" STUDY OVE... (ID 5360)
Companies Profiled: Biogen, Sanofi, Novartis
Price: $2000.00


Direct access to this research is not included with your membership level.This is a pharma specific study.Incivek Case Study: A Well Planned and Executed Launch Makes the Most of a Small Window of Opportunity This document contains Metrics and Graphics.This document contains Metrics and Graphics.
Non-members: Click here to review a complimentary excerpt from "Incivek Case Study: A Well Planned and Executed Launch Makes the Most of a Small Wind... (ID 5346)
Companies Profiled: Merck, Gilead Sciences, Vertex Pharmaceuticals
Price: $1770.00


Direct access to this research is not included with your membership level.This is a pharma specific study.Effexor Case Study: Using an Efficacy Message to Drive a Brand to the Top of a Crowded Market This document contains Metrics and Graphics.This document contains Metrics and Graphics.
Non-members: Click here to review a complimentary excerpt from "Effexor Case Study: Using an Efficacy Message to Drive a Brand to the Top of a Crowde... (ID 5220)
Companies Profiled: Wyeth
Price: $1800.00


Direct access to this research is not included with your membership level.This is a pharma specific study.Diovan Case Study: Long-Term Brand Building in The Competitive Antihypertensive Market This document contains Metrics and Graphics.This document contains Metrics and Graphics.
Non-members: Click here to review a complimentary excerpt from "Diovan Case Study: Long-Term Brand Building in the Competitive Antihypertensive Marke... (ID 5222)
Companies Profiled: Novartis
Price: $2890.00


Direct access to this research is not included with your membership level.This is a pharma specific study.Cymbalta Case Study: Using Market-Entry Delays to Develop Customer Insights that Help Grow a Blockbuster This document contains Metrics and Graphics.This document contains Metrics and Graphics.
Non-members: Click here to review a complimentary excerpt from "Cymbalta Case Study: Using Market Entry Delays to Develop Customer Insights that Help... (ID 5221)
Companies Profiled: Eli Lilly
Price: $3120.00


Direct access to this research is not included with your membership level.This is a pharma specific study.Onglyza Case Study: Lack of Differentiation Mutes a Launch This document contains Metrics and Graphics.This document contains Metrics and Graphics.
Non-members: Click here to review a complimentary excerpt from "Onglyza Case Study: Lack of Differentiation Mutes a Launch" STUDY OVERVIEW Onglyza, a... (ID 5109)
Companies Profiled: Bristol-Myers Squibb, AstraZeneca
Price: $2760.00   Free Excerpt Available


Direct access to this research is not included with your membership level.This is a pharma specific study.Gardasil Case Study: Using Policy as a Springboard for Launch Success This document contains Metrics and Graphics.This document contains Metrics and Graphics.
Non-members: Click here to review a complimentary excerpt from "Gardasil Case Study: Using Policy as a Springboard For Launch Success" STUDY OVERVIE... (ID 5108)
Companies Profiled: Merck
Price: $3381.00   Free Excerpt Available


Direct access to this research is not included with your membership level.This is a pharma specific study.Effient Case Study: Stumbling When Taking On The Market Leader This document contains Metrics and Graphics.This document contains Metrics and Graphics.
Non-members: Click here to review a complimentary excerpt from "Effient Case Study: Stumbling When Taking On The Market Leader" STUDY OVERVIEW The bl... (ID 5107)
Companies Profiled: Eli Lilly, Daiichi Sankyo
Price: $4500.00   Free Excerpt Available


Direct access to this research is not included with your membership level.This is a pharma specific study.Januvia Case Study: Building a Successful Launch Around KOL, Physician, Patient and Payer Education This document contains Metrics and Graphics.This document contains Metrics and Graphics.
Non-members: Click here to review a complimentary excerpt from "Januvia Case Study: Building a Successful Launch Around KOL, Physician, Patient and P... (ID 5106)
Companies Profiled: Merck
Price: $4500.00


Direct access to this research is not included with your membership level.This is a pharma specific study.The Many Faces of HIV Advocacy: A Case Study of Advocacy Initiatives in the HIV/ AIDS Therapeutic Area This document contains Graphics.
Non-members: Click here to review a complimentary excerpt from "The Many Faces of HIV Advocacy: A Case Study of Advocacy Initiatives in the HIV/ AIDS... (ID 5074)
Companies Profiled: Gilead Sciences, Abbott, Merck, GlaxoSmithKline
Price: $695.00   Free Excerpt Available


FirstPrevious set of DocumentsNext set of DocumentsLast
First | Previous set of DocumentsPrevious | NextNext set of Documents | Last

 
ACCESS AND INTELLIGENCE FOR ACHIEVING WORLD-CLASS EXCELLENCE
Quick Links  Product RSS Feed
Payment gateway
Secured by PayPal

Follow Us: 

linkedin twitter slideshare youtube google + pinterest

All contents copyright 1998-2020 Best Practices, LLC (919) 403-0251
Read our Terms and Conditions of Use, Privacy Policy and Copyright Information